Literature DB >> 75177

The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.

A W Hill, A L Shears, K G Hibbitt.   

Abstract

Experiments using the selective divalent cation chelator, ethylene glycol tetraacetic acid (EGTA) showed that the alternate complement pathway was involved in the bactericidal action of bovine serum on two strains of E. coli. The bactericidal system was shown, in experiments involving EGTA and epsilon-amino caproic acid, to be independent of Ca++ and the C1 unit of complement. The fixation of the complement components C3-C9 by endotoxin does not require a functional classical pathway ((C1, C4 and C2). In the case of one coliform strain (W1) however, there was an almost total dependence on a factor absorbable at 0 degrees with homologous bacteria, and which appeared to be a natural antibody. These results suggest that in certain circumstances in the cow, gamma globulins may be directly involved in the activation of the alternate complement pathway.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 75177      PMCID: PMC1457330     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.

Authors:  N A Soter; K F Austen; I Gigli
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

2.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

3.  Contributions of the classical and alternate complement pathways to the biological effects of endotoxin.

Authors:  M M Frank; J E May; M A Kane
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

4.  Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.

Authors:  J K Phillips; R Snyderman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

5.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Activation of the classic and alternate complement pathways by endotoxin.

Authors:  D P Fine
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

7.  Sensitization of E. coli to the serum bactericidal system and to lysozyme by ethyleneglycoltetraacetic acid.

Authors:  C S Bryan
Journal:  Proc Soc Exp Biol Med       Date:  1974-04

8.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

9.  Effect of C4 depletion on the utilization of the terminal components of guinea-pig complement by endotoxin.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen; J Jensen
Journal:  Nat New Biol       Date:  1971-06-02

10.  The role of properdin in the alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  7 in total

1.  Antibody enhances killing of Tritrichomonas foetus by the alternative bovine complement pathway.

Authors:  M K Aydintug; R W Leid; P R Widders
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.

Authors:  R A Eisenberg; J H Schwab
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

3.  Serum IgG levels and complement activity in hypogammaglobulinaemic patients under substitution therapy.

Authors:  A Plebani; L D Notarangelo; M Duse; A Avanzini; M Massa; A G Ugazio
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Participation of normal human immunoglobulins M, G, and A in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by human polymorphonuclear leukocytes.

Authors:  A B Bjornson; H S Bjornson; B P Kitko
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

5.  Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.

Authors:  N P Steele; R S Munson; D M Granoff; J E Cummins; R P Levine
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilli.

Authors:  P Leist-Welsh; A B Bjornson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.

Authors:  K A Joiner; L F Fries; M A Schmetz; M M Frank
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.